1. Home
  2. LEXX vs MNY Comparison

LEXX vs MNY Comparison

Compare LEXX & MNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • MNY
  • Stock Information
  • Founded
  • LEXX 2004
  • MNY 2014
  • Country
  • LEXX Canada
  • MNY Singapore
  • Employees
  • LEXX N/A
  • MNY N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • MNY
  • Sector
  • LEXX Health Care
  • MNY
  • Exchange
  • LEXX Nasdaq
  • MNY Nasdaq
  • Market Cap
  • LEXX 38.6M
  • MNY 47.1M
  • IPO Year
  • LEXX N/A
  • MNY N/A
  • Fundamental
  • Price
  • LEXX $2.20
  • MNY $1.08
  • Analyst Decision
  • LEXX Strong Buy
  • MNY
  • Analyst Count
  • LEXX 2
  • MNY 0
  • Target Price
  • LEXX $11.00
  • MNY N/A
  • AVG Volume (30 Days)
  • LEXX 182.7K
  • MNY 162.8K
  • Earning Date
  • LEXX 01-10-2025
  • MNY 12-10-2024
  • Dividend Yield
  • LEXX N/A
  • MNY N/A
  • EPS Growth
  • LEXX N/A
  • MNY N/A
  • EPS
  • LEXX N/A
  • MNY N/A
  • Revenue
  • LEXX $464,278.00
  • MNY $90,185,081.00
  • Revenue This Year
  • LEXX $20.39
  • MNY $26.64
  • Revenue Next Year
  • LEXX $113.25
  • MNY $25.46
  • P/E Ratio
  • LEXX N/A
  • MNY N/A
  • Revenue Growth
  • LEXX 105.24
  • MNY 24.60
  • 52 Week Low
  • LEXX $1.20
  • MNY $0.85
  • 52 Week High
  • LEXX $6.85
  • MNY $3.46
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 47.08
  • MNY 43.30
  • Support Level
  • LEXX $2.14
  • MNY $1.03
  • Resistance Level
  • LEXX $2.38
  • MNY $1.15
  • Average True Range (ATR)
  • LEXX 0.17
  • MNY 0.08
  • MACD
  • LEXX 0.01
  • MNY -0.00
  • Stochastic Oscillator
  • LEXX 40.74
  • MNY 22.81

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About MNY MoneyHero Limited

MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.

Share on Social Networks: